Genetic profiles of gastroesophageal cancer: Combined analysis using expression array and tiling array-comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 200, Issue 2, 2010, Pages 120-126

  Isinger Ekstrand, Anna ^a   Johansson, Jan ^b   Ohlsson, Mattias ^a   Francis, Princy ^a   Staaf, Johan ^a   Jönsson, Mats ^a   Borg, Åke ^a   Nilbert, Mef ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 2Q; CHROMOSOME 5P; CHROMOSOME 7P; CHROMOSOME 8Q; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOSS; GENE NUMBER; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION; Y CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLIN-DEPENDENT KINASE 6; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS;

EID: 77953805124     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.03.013     Document Type: Article

References (34)

1. Lambert R., Hainaut P. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer. Best Pract Res Clin Gastroenterol 2007, 21:921-945.
2. Forman D. Oesophago-gastric adenocarcinoma-an epidemiological perspective (review). Aliment Pharmacol Ther 2004, 20(Suppl 5):55-60.
3. Kalish R.J., Clancy P.E., Orringer M.B., Appelman H.D. Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. Gastroenterology 1984, 86:461-467.
4. Ruol A., Parenti A., Zaninotto G., Merigliano S., Costantini M., Cagol M., Alfieri R., Bonavina L., Peracchia A., Ancona E. Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000, 88:2520-2528.
5. Siewert J.R., Stein H.J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998, 85:1457-1459.
6. Riegman P.H., Vissers K.J., Alers J.C., Geelen E., Hop W.C., Tilanus H.W., et al. Genomic alterations in malignant transformation of Barrett's esophagus. Cancer Res 2001, 61:3164-3170.
7. Wu T.T., Watanabe T., Heitmiller R., Zahurak M., Forastiere A.A., Hamilton S.R. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol 1998, 153:287-294.
8. El-Rifai W., Frierson H.F., Moskaluk C.A., Harper J.C., Petroni G.R., Bissonette E.A., et al. Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa. Gastroenterology 2001, 121:592-598.
9. van Dekken H., Geelen E., Dinjens W.N., Wijnhoven B.P., Tilanus H.W., Tanke H.J., et al. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res 1999, 59:748-752.
10. Menke-Pluymers M.B., van Drunen E., Vissers K.J., Mulder A.H., Tilanus H.W., Hagemeijer A. Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. Cancer Genet Cytogenet 1996, 90:109-117.
11. Moskaluk C.A., Hu J., Perlman E.J. Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosomes Cancer 1998, 22:305-311.
12. Varis A., Puolakkainen P., Savolainen H., Kokkola A., Salo J., Nieminen O., et al. DNA copy number profiling in esophageal Barrett adenocarcinoma: comparison with gastric adenocarcinoma and esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2001, 127:53-58.
13. Jonsson G., Staaf J., Olsson E., Heidenblad M., Vallon-Christersson J., Osoegawa K., et al. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 2007, 46:543-558.
14. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001, 29:263-264.
15. Jonsson G., Naylor T.L., Vallon-Christersson J., Staaf J., Huang J., Ward M.R., et al. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res 2005, 65:7612-7621.
16. Saal L.H., Troein C., Vallon-Christersson J., Gruvberger S., Borg A., Peterson C. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 2002, 3. SOFTWARE0003.
17. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 30:e15.
18. Fernebro J., Francis P., Eden P., Borg A., Panagopoulos I., Mertens F., et al. Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. Int J Cancer 2006, 118:1165-1172.
19. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121.
20. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
21. Aust D.E., Muders M., Kohler A., Schmidt M., Diebold J., Muller C., et al. Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis. Scand J Gastroenterol 2004, 39:766-772.
22. Isola J.J., Kallioniemi O.P., Chu L.W., Fuqua S.A., Hilsenbeck S.G., Osborne C.K., et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995, 147:905-911.
23. Hibi K., Nakamura H., Hirai A., Fujikake Y., Kasai Y., Akiyama S., et al. Loss of H19 imprinting in esophageal cancer. Cancer Res 1996, 56:480-482.
24. Hourihan R.N., O'Sullivan G.C., Morgan J.G. Transcriptional gene expression profiles of oesophageal adenocarcinoma and normal oesophageal tissues. Anticancer Res 2003, 23:161-165.
25. Tselepis C., Morris C.D., Wakelin D., Hardy R., Perry I., Luong Q.T., et al. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 2003, 52:174-180.
26. Hughes S.J., Glover T.W., Zhu X.X., Kuick R., Thoraval D., Orringer M.B., et al. A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc Natl Acad Sci USA 1998, 95:12410-12415.
27. Mitas M., Almeida J.S., Mikhitarian K., Gillanders W.E., Lewin D.N., Spyropoulos D.D., et al. Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res 2005, 11:2205-2214.
28. Holcombe R.F., Marsh J.L., Waterman M.L., Lin F., Milovanovic T., Truong T. Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol 2002, 55:220-226.
29. Mendrzyk F., Radlwimmer B., Joos S., Kokocinski F., Benner A., Stange D.E., et al. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol 2005, 23:8853-8862.
30. van Dekken H., van Marion R., Vissers K.J., Hop W.C., Dinjens W.N., Tilanus H.W., et al. Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels. Genes Chromosomes Cancer 2008, 47:649-656.
31. al-Kasspooles M., Moore J.H., Orringer M.B., Beer D.G. Amplification and over-expression of the EGFR and erbB-2 genes in human esophageal adenocarcinomas. Int J Cancer 1993, 54:213-219.
32. Miller C.T., Moy J.R., Lin L., Schipper M., Normolle D., Brenner D.E., et al. Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia. Clin Cancer Res 2003, 9:4819-4825.
33. Rygiel A.M., Milano F., Ten Kate F.J., Schaap A., Wang K.K., Peppelenbosch M.P., et al. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2008, 17:1380-1385.
34. Wang K.L., Wu T.T., Choi I.S., Wang H., Resetkova E., Correa A.M., et al. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer 2007, 109:658-667.